FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015016716> ?p ?o ?g. }

• W2015016716 endingPage "598" @default.
• W2015016716 startingPage "593" @default.
• W2015016716 abstract "The transdermal delivery system (TDS) is able to obtain a systemic therapeutic effect by administration through the skin, which has low side effects and is able to maintain a sustained blood concentration. However, due to the barrier presented by the stratum corneum, numerous drugs have poor percutaneous permeability. Therefore, the improvement of skin permeability is key to TDS. The main method of promoting transdermal absorption is through the usage of penetration enhancers. Dimethyl sulfoxide (DMSO) is a commonly used penetration enhancer, which has anti‑inflammatory analgesic effects and is able to penetrate the skin. Retinoic acid (RA) and lipolanthionine peptide (LP) may also benefit the permeation efficiency of TDS. Therefore, the present study examined the function of DMSO, RA and LP as penetration enhancers in TDS. Firstly, the optimum concentration of DMSO was confirmed by detecting the expression of the LacZ gene in vitro. Secondly, different combinations of LP, RA and DMSO were applied to mouse skin to analyze the penetration enhancer combination with the greatest efficacy. All the animals were divided into five groups: The RA + LP + DMSO + pORF‑LacZ group, the RA + DMSO + pORF‑LacZ group, the LP + DMSO + pORF‑LacZ group, the DMSO + pORF-LacZ group and the control group. Skin was soaked in combinations of LP, RA and DMSO for seven days and then the pORF‑LacZ plasmids were daubed onto the skin once daily three days. On the 11th day, all the animals were sacrificed by cervical dislocation and the skin and blood samples were collected. The blood samples were used to detect the expression of the LacZ gene by quantitative polymerase chain reaction and the skin samples were used to detect the expression of claudin‑4 and zonula occluden‑1 (ZO‑1) proteins by immunohistochemistry and western blot analysis. The results demonstrated that the combination of LP, RA and DMSO exhibited the greatest transdermal delivery efficiency, which verified that RA and LP were able to increase the penetration effects. Following treatment with LP, the symptoms of dermal edema were relieved and the capillaries contracted, which suggested that LP was a safe and effective penetration enhancer able to reduce the side‑effects caused by DMSO. The present study provides a guideline for the synthesis of novel penetration enhancers." @default.
• W2015016716 created "2016-06-24" @default.
• W2015016716 creator A5011229496 @default.
• W2015016716 creator A5026663904 @default.
• W2015016716 creator A5052007875 @default.
• W2015016716 creator A5052254671 @default.
• W2015016716 creator A5058449525 @default.
• W2015016716 creator A5072605927 @default.
• W2015016716 creator A5077789804 @default.
• W2015016716 creator A5081263654 @default.
• W2015016716 date "2014-05-20" @default.
• W2015016716 modified "2023-09-27" @default.
• W2015016716 title "Use of lipolanthionine peptide, a toll-like receptor 2 inhibitor, enhances transdermal delivery efficiency" @default.
• W2015016716 cites W1553749544 @default.
• W2015016716 cites W1758327849 @default.
• W2015016716 cites W1930598094 @default.
• W2015016716 cites W1975088129 @default.
• W2015016716 cites W1975156128 @default.
• W2015016716 cites W1978537309 @default.
• W2015016716 cites W1983422677 @default.
• W2015016716 cites W1984087874 @default.
• W2015016716 cites W1993649482 @default.
• W2015016716 cites W1993764658 @default.
• W2015016716 cites W2007055163 @default.
• W2015016716 cites W2010502574 @default.
• W2015016716 cites W2011337627 @default.
• W2015016716 cites W2016787709 @default.
• W2015016716 cites W2017080463 @default.
• W2015016716 cites W2018116705 @default.
• W2015016716 cites W2019019161 @default.
• W2015016716 cites W2029554393 @default.
• W2015016716 cites W2036379364 @default.
• W2015016716 cites W2036677115 @default.
• W2015016716 cites W2053632425 @default.
• W2015016716 cites W2058838095 @default.
• W2015016716 cites W2070214421 @default.
• W2015016716 cites W2083864310 @default.
• W2015016716 cites W2088893744 @default.
• W2015016716 cites W2133038403 @default.
• W2015016716 cites W2133752997 @default.
• W2015016716 cites W2143616792 @default.
• W2015016716 cites W2326381911 @default.
• W2015016716 doi "https://doi.org/10.3892/mmr.2014.2251" @default.
• W2015016716 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4094769" @default.
• W2015016716 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24858729" @default.
• W2015016716 hasPublicationYear "2014" @default.
• W2015016716 type Work @default.
• W2015016716 sameAs 2015016716 @default.
• W2015016716 citedByCount "2" @default.
• W2015016716 countsByYear W20150167162016 @default.
• W2015016716 crossrefType "journal-article" @default.
• W2015016716 hasAuthorship W2015016716A5011229496 @default.
• W2015016716 hasAuthorship W2015016716A5026663904 @default.
• W2015016716 hasAuthorship W2015016716A5052007875 @default.
• W2015016716 hasAuthorship W2015016716A5052254671 @default.
• W2015016716 hasAuthorship W2015016716A5058449525 @default.
• W2015016716 hasAuthorship W2015016716A5072605927 @default.
• W2015016716 hasAuthorship W2015016716A5077789804 @default.
• W2015016716 hasAuthorship W2015016716A5081263654 @default.
• W2015016716 hasBestOaLocation W20150167161 @default.
• W2015016716 hasConcept C104317684 @default.
• W2015016716 hasConcept C111936080 @default.
• W2015016716 hasConcept C127413603 @default.
• W2015016716 hasConcept C150194340 @default.
• W2015016716 hasConcept C178790620 @default.
• W2015016716 hasConcept C185592680 @default.
• W2015016716 hasConcept C202751555 @default.
• W2015016716 hasConcept C205679159 @default.
• W2015016716 hasConcept C2778370115 @default.
• W2015016716 hasConcept C2778452553 @default.
• W2015016716 hasConcept C42475967 @default.
• W2015016716 hasConcept C54355233 @default.
• W2015016716 hasConcept C55493867 @default.
• W2015016716 hasConcept C80107235 @default.
• W2015016716 hasConcept C86803240 @default.
• W2015016716 hasConcept C98274493 @default.
• W2015016716 hasConceptScore W2015016716C104317684 @default.
• W2015016716 hasConceptScore W2015016716C111936080 @default.
• W2015016716 hasConceptScore W2015016716C127413603 @default.
• W2015016716 hasConceptScore W2015016716C150194340 @default.
• W2015016716 hasConceptScore W2015016716C178790620 @default.
• W2015016716 hasConceptScore W2015016716C185592680 @default.
• W2015016716 hasConceptScore W2015016716C202751555 @default.
• W2015016716 hasConceptScore W2015016716C205679159 @default.
• W2015016716 hasConceptScore W2015016716C2778370115 @default.
• W2015016716 hasConceptScore W2015016716C2778452553 @default.
• W2015016716 hasConceptScore W2015016716C42475967 @default.
• W2015016716 hasConceptScore W2015016716C54355233 @default.
• W2015016716 hasConceptScore W2015016716C55493867 @default.
• W2015016716 hasConceptScore W2015016716C80107235 @default.
• W2015016716 hasConceptScore W2015016716C86803240 @default.
• W2015016716 hasConceptScore W2015016716C98274493 @default.
• W2015016716 hasIssue "2" @default.
• W2015016716 hasLocation W20150167161 @default.
• W2015016716 hasLocation W20150167162 @default.
• W2015016716 hasLocation W20150167163 @default.
• W2015016716 hasLocation W20150167164 @default.
• W2015016716 hasOpenAccess W2015016716 @default.

• next